Chitosan glutamate nanoparticles for protein delivery: Development and effect on prolidase stability
暂无分享,去创建一个
P. Perugini | B. Conti | I. Genta | T. Modena | F. Pavanetto | R. Dorati | C. Colonna | Claudia Colonna | Bice Conti | Paola Perugini | Franca Pavanetto | Tiziana Modena | Rossella Dorati | Ida Genta
[1] Robert A Freitas,et al. What is nanomedicine? , 2005, Disease-a-month : DM.
[2] R. Muzzarelli. Colorimetric determination of chitosan. , 1998, Analytical biochemistry.
[3] P. Iadarola,et al. The role of emerging techniques in the investigation of prolidase deficiency: from diagnosis to the development of a possible therapeutical approach. , 2006, Journal of chromatography. B, Analytical technologies in the biomedical and life sciences.
[4] V. Sinha,et al. Biodegradable microspheres for protein delivery. , 2003, Journal of controlled release : official journal of the Controlled Release Society.
[5] M. Alonso,et al. Novel hydrophilic chitosan‐polyethylene oxide nanoparticles as protein carriers , 1997 .
[6] Nicholas A Peppas,et al. Nanoscale technology of mucoadhesive interactions. , 2004, Advanced drug delivery reviews.
[7] Tejraj M Aminabhavi,et al. Recent advances on chitosan-based micro- and nanoparticles in drug delivery. , 2004, Journal of controlled release : official journal of the Controlled Release Society.
[8] Y. Machida,et al. Biodegradation and distribution of water-soluble chitosan in mice. , 1999, Biomaterials.
[9] E. Hartree,et al. Determination of protein: a modification of the Lowry method that gives a linear photometric response. , 1972, Analytical biochemistry.
[10] Jayanth Panyam,et al. Biodegradable nanoparticles for drug and gene delivery to cells and tissue. , 2003, Advanced drug delivery reviews.
[11] Gerrit Borchard,et al. The potential of mucoadhesive polymers in enhancing intestinal peptide drug absorption. III: Effects of chitosan-glutamate and carbomer on epithelial tight junctions in vitro , 1996 .
[12] L. Lim,et al. Ultrasonication of chitosan and chitosan nanoparticles. , 2003, International journal of pharmaceutics.
[13] J. Lowe,et al. Chitosan as a nasal delivery system: the effect of chitosan solutions on in vitro and in vivo mucociliary transport rates in human turbinates and volunteers. , 1997, Journal of pharmaceutical sciences.
[14] Tao Wang,et al. Modulation of surface charge, particle size and morphological properties of chitosan-TPP nanoparticles intended for gene delivery. , 2005, Colloids and surfaces. B, Biointerfaces.
[15] K. Janes,et al. Polysaccharide colloidal particles as delivery systems for macromolecules. , 2001, Advanced drug delivery reviews.
[16] R. Rappuoli,et al. A mucosal vaccine against diphtheria: formulation of cross reacting material (CRM(197)) of diphtheria toxin with chitosan enhances local and systemic antibody and Th2 responses following nasal delivery. , 2000, Vaccine.
[17] P Buri,et al. Chitosan: a unique polysaccharide for drug delivery. , 1998, Drug development and industrial pharmacy.
[18] M. Ashokkumar,et al. Sonochemistry and Sonoluminescence in Colloidal Systems , 1999 .
[19] C. P. Sharma,et al. Use of chitosan as a biomaterial: studies on its safety and hemostatic potential. , 1997, Journal of biomedical materials research.
[20] Jiyoung M Dang,et al. Natural polymers for gene delivery and tissue engineering. , 2006, Advanced drug delivery reviews.